Skip to content
TrialScanner

NCT02054884

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma

Phase 2TerminatedIMTXCollaborator

Registry record

Lead sponsor
Philogen S.p.A.
Conditions
Merkel Cell Carcinoma
Primary completion
Dec 31, 2016Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02054884 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02054884: F16IL2 Plus Paclitaxel in... | TrialScanner